Alector, Inc. Common Stock (ALEC)

Price$1.53

Value ScoreC

Growth ScoreF

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)21.95%

Price vs S&P 500 (4W)-30.35%

VGM Score34.77

Market Capitalization$169.87M

All Metrics

Book Value / Share (Quarterly)$0.09

P/TBV (Annual)1.97x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-45.99%

Cash Flow / Share (Quarterly)$-1.56

Price vs S&P 500 (YTD)-7.55%

Net Profit Margin (TTM)-680.83%

EPS (TTM)$-1.19

10-Day Avg Trading Volume0.77M

EPS Excl Extra (TTM)$-1.19

Revenue Growth (5Y)-0.05%

EPS (Annual)$-1.39

ROI (Annual)-354.33%

Net Profit Margin (5Y Avg)-209.84%

Cash / Share (Quarterly)$1.86

Revenue Growth QoQ (YoY)-71.53%

ROA (Last FY)-48.74%

Revenue Growth TTM (YoY)-79.15%

EBITD / Share (TTM)$-1.23

ROE (5Y Avg)-146.33%

Operating Margin (TTM)-739.70%

Cash Flow / Share (Annual)$-1.67

P/B Ratio16.36x

P/B Ratio (Quarterly)22.85x

Net Income / Employee (Annual)$-1,387,700

EV / Revenue (TTM)5.57x

ROA (TTM)-40.95%

EV / EBITDA (TTM)2.43x

EPS Incl Extra (Annual)$-1.39

Current Ratio (Annual)3.83x

Quick Ratio (Quarterly)5.04x

3-Month Avg Trading Volume0.74M

52-Week Price Return-3.68%

Revenue / Employee (TTM)$178,800

Tangible BV / Share (Quarterly)$1.93

P/S Ratio (Annual)8.07x

Asset Turnover (Annual)0.07x

52-Week High$3.40

Operating Margin (5Y Avg)-232.60%

EPS Excl Extra (Annual)$-1.39

CapEx CAGR (5Y)-61.74%

Tangible BV CAGR (5Y)53.15%

26-Week Price Return29.75%

Quick Ratio (Annual)3.68x

13-Week Price Return-32.33%

Total Debt / Equity (Annual)0.32x

Current Ratio (Quarterly)5.25x

Enterprise Value$102.67M

Revenue / Share Growth (5Y)-5.51%

Asset Turnover (TTM)0.06x

Book Value / Share Growth (5Y)-39.32%

Revenue / Employee (Annual)$204,300

Pretax Margin (Annual)-678.36%

Cash / Share (Annual)$2.32

3-Month Return Std Dev76.49%

Net Income / Employee (TTM)$-1,217,400

ROE (Last FY)-466.34%

EPS Basic Excl Extra (Annual)$-1.39

Receivables Turnover (TTM)74.61x

Total Debt / Equity (Quarterly)0.94x

EPS Incl Extra (TTM)$-1.19

Receivables Turnover (Annual)74.66x

ROI (TTM)-240.53%

P/S Ratio (TTM)9.22x

Pretax Margin (5Y Avg)-208.10%

Revenue / Share (Annual)$0.20

Tangible BV / Share (Annual)$2.59

Price vs S&P 500 (52W)-26.36%

Year-to-Date Return0.64%

5-Day Price Return-3.98%

EPS Normalized (Annual)$-1.39

ROA (5Y Avg)-23.30%

Net Profit Margin (Annual)-679.16%

Month-to-Date Return-27.31%

Cash Flow / Share (TTM)$-1.58

EBITD / Share (Annual)$-1.46

Operating Margin (Annual)-741.30%

LT Debt / Equity (Annual)0.30x

ROI (5Y Avg)-122.63%

LT Debt / Equity (Quarterly)0.80x

EPS Basic Excl Extra (TTM)$-1.19

P/TBV (Quarterly)2.60x

P/B Ratio (Annual)5.56x

Pretax Margin (TTM)-679.92%

Book Value / Share (Annual)$0.28

Price vs S&P 500 (13W)-41.41%

Beta0.64x

P/FCF (Annual)0.57x

Revenue / Share (TTM)$0.17

ROE (TTM)-295.17%

52-Week Low$1.09

vGradeC

gGradeF

mGradeC

vgmGradeD

Show chart for

Earnings Surprise History

Q1 26-0.21est. -0.35

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

2.54

2.69

3.64

Industry Peers — Biological Products(179)

Symbol	Value Score	Growth Score	Momentum Score	Price
ALECAlector, Inc. Common Stock	C	F	C	$1.53
AMGNAmgen Inc	C	C	C	$355.20
GILDGilead Sciences Inc	C	B	C	$125.59
ARGXargenx SE American Depositary Shares	D	A	B	$893.52
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$153.87
BIIBBiogen Inc. Common Stock	B	D	B	$200.05
BNTXBioNTech SE American Depositary Share	C	C	C	$90.54
MRNAModerna, Inc. Common Stock	C	B	B	$49.91
NBIXNeurocrine Biosciences Inc	C	B	B	$159.76
EXELExelixis Inc	C	B	B	$53.13
KRYSKrystal Biotech, Inc. Common Stock	D	B	A	$317.97

About

Alector Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegeneration. The company's approach focuses on restoring healthy immune function in the brain to counteract underlying pathologies. Its pipeline includes multiple therapeutic candidates, including AL001, AL002, AL003, and AL101.